SCHEMBL21708709

SCHEMBL21708709

CCCC(F)OC(=O)CC(CN)c1ncccc1OC

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGFR P43088 3/20 0.35
RAB9A P51151 3/20 0.33
NPC1 O15118 2/20 0.33
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
HTT P42858 4/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32
GAA P10253 1/20 0.32
TSHR P16473 1/20 0.32
PLAU P00749 1/20 0.32
LMNA P02545 3/20 0.32
HPGD P15428 1/20 0.32
TDP1 Q9NUW8 3/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPK1 P28482 2/20 0.32
PKM P14618 1/20 0.32
CTSA P10619 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21708643 0.83 POLB (0.45) TAS1R3TAS1R1HTTMEN1KMT2A
SCHEMBL21708763 0.82 S1PR1 (0.35) PTGFRRAB9ANPC1TAS1R3TAS1R1
SCHEMBL21708665 0.80 GAA (0.38) RAB9AMEN1MAPTKMT2AGAA
SCHEMBL21708747 0.79 TAS1R3 (0.36) PTGFRRAB9ANPC1TAS1R3TAS1R1
SCHEMBL21631944 0.79 GAA (0.50) PTGFRHTTMEN1MAPTKMT2A
SCHEMBL21656117 0.78 RAB9A (0.36) PTGFRRAB9ANPC1HTTGAA
Hydrochloric Acid SCHEMBL21708784 0.78 GAA (0.37) PTGFRTAS1R3TAS1R1GAAKDM4E
Hydrochloric Acid SCHEMBL21708730 0.76 CTDSP1 (0.36) PTGFRRAB9AHTTMEN1KMT2A
SCHEMBL21708590 0.75 L3MBTL1 (0.41) RAB9ATAS1R3TAS1R1HTTMEN1
SCHEMBL21708792 0.72 TAS1R3 (0.33) TAS1R3TAS1R1MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed